OmniAb Investor Presentation Deck
Antibodies and Industry Demand
HIGHER CLINICAL SUCCESS RATES FOR ANTIBODY MEDICINES DRIVE OUR INDUSTRY'S NEED
FOR DISCOVERY TECHNOLOGY
Increasing Antibody Market
ā
$279B in antibody sales by 2025 (up from ~$238B in 2022)
51 blockbuster antibodies in 2022
5 best-selling antibodies had ~$75B of sales in 2022
Higher Success Rates
Type of Drug
Small Molecules
Antibodies
Clinical Success Rates (1)
7.5%
12.1%
Historical
success rates
for antibodies are
significantly higher
than small
molecules
Acceleration of Regulatory
Approvals (FDA and EMA)
70
60
50
40
30
20
10
0
Substantial
growth in
number of
new antibody
therapeutics
Pre-2000 2001-2010 2011-2020
Sources:
Clarivate Analytics Cortellis database. Tables of approved mAbs and antibodies in review available at: https://www.antibodysociety.org/resources/approved-antibodies/
(1) Defined as composite success rate of clinical development from Phase I trials to Approval, data from 2011-2020. Source: BIO | QLS Advisors | Informa Feb 2021 Report.
LO
5
OmniAbView entire presentation